RSS
Sitemap
Login (HMA-DMS)
Contact
Search
About HMA
Human Medicines
Veterinary Medicines
You are here:
Home
>
Human Medicines
>
CMDh
>
Procedural Guidance
>
Variation
>
Art 5 recommendations
CMDh
About CMDh
Statistics
Agendas and Minutes
Press Releases
COVID-19
BREXIT
Nitrosamine impurities
Procedural Guidance
General Info
Application for MA
eSubmissions
Generics
Applicant´s Responses
Renewal
Consultation with target patient groups
Variation
Amended Variation Regulation
Art 5 recommendations
USR
Art 61.3 Procedure
Post Referral Phase
CMDh-Referrals
Product Information
Advice from CMDh
Templates
CMD Working Parties / Working Groups
Paediatric Regulation
Pharmacovigilance
Falsified Medicines
Questions & Answers
Contact Points
Recently Published history
MRI Product Index
Pharmacovigilance
Availability of Medicines
Publications and reports
National Contacts
Art.5 on Unforeseen Variations
CMDh Recommendation for classification of unforeseen variations according to Article 5 of Commission Regulation (EC) 1234/2008
(March 2023)
Templates
Template of the Article 5
